Profile
APDN DHR-PB TMO DHR IDXX A
Company Name Applied DNA Sciences, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $2.54M $916.76B $164.16B $145.42B $43.07B $33.87B
Employees 0.05K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO James A. Hayward Sc.D. Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
APDN DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
APDN DHR-PB TMO DHR IDXX A
Last Close $4.57 $1261.26 $463.04 $197.09 $535.54 $113.5
High 52 $5.71 $1261.26 $624.21 $278.02 $573.07 $152.6
Low 52 $0.05 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -19.96 % 0 % -25.82 % -29.11 % -6.55 % -25.62 %
Price vs. 52 Week Low 9040 % 0 % 18.67 % 12.86 % 48.33 % 14.31 %
Total Return
APDN DHR-PB TMO DHR IDXX A
1 Month Return -7.41 % 0 % 8.25 % -2.67 % -1.32 % -5.93 %
3 Month Return 412.91 % 0 % 9.32 % -0.98 % 13.49 % 4.48 %
6 Month Return 2509.94 % 0 % -22.54 % -11.52 % 26.89 % -25.09 %
9 Month Return 2228.07 % 0 % -17.01 % -20.45 % 28.34 % -17.07 %
YTD Return 2140.2 % 0 % -10.99 % -14.14 % 29.53 % -15.51 %
1 Year Return 1113.49 % 0 % -24.79 % -28.78 % 14.28 % -18.37 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APDN DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.57 % 0.38 % 0.58 % - 0.82 %
Dividend Paid and Capex Coverage Ration (TTM) -0.34 % 3.26 % 4.05 % 2.93 % 7.41 % 3.43 %
Dividend Per Share (TTM) - 1.18 % 1.64 % 1.18 % - 0.98 %
Payout Ratio (TTM) -124.13 % 17.14 % 9.16 % 20.85 % - 23.76 %
Profitability
APDN DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 40.76 % 59.66 % 41.57 % 59.74 % 61.32 % 53.79 %
Return on Assets TTM -239.96 % 4.18 % 6.58 % 4.76 % 27.85 % 9.59 %
Return on Equity TTM -281.09 % 6.69 % 13.34 % 7.47 % 57.35 % 19.46 %
Return on Capital Employed TTM -117.07 % 5.9 % 8.53 % 6.66 % 55.24 % 13.97 %
Net Income Per EBT TTM 418.79 % 83.73 % 92.18 % 83.59 % 79.59 % 85.05 %
EBT Per Ebit TTM 57.26 % 92.28 % 96.45 % 93.35 % 97.98 % 96.75 %
EBIT Per Revenue TTM -344.11 % 18.39 % 17.08 % 20.26 % 29.19 % 21.38 %
Cash Flow To Debt Ratio TTM -2805.91 % 35.55 % 23.81 % 37.92 % 91.41 % 45.35 %
Receivables Turnover TTM 5.49 6.74 5.07 6.79 6.51 4.85
Payables Turnover TTM - 5.62 - 5.57 12.66 5.94
Inventory Turnover TTM 6.44 3.6 4.8 3.79 3.84 3.1
Fixed Asset Turnover TTM 327.83 % 452.31 % 459.74 % 466.14 % 471.66 % 346.65 %
Asset Turnover TTM 29.08 % 29.42 % 43.31 % 30.11 % 122.35 % 54.52 %
Operating Cash Flow Per Share TTM -7.48 8.61 21.53 8.72 11.91 5.56
Free Cash Flow Per Share TTM -7.87 6.79 17.79 6.84 10.3 4.91
Cash Per Share TTM 384.82 % 412.7 % 1573.28 % 278.24 % 201.64 % 521.4 %
Operating Cash Flow Sales Ratio TTM -349.67 % 25.69 % 18.97 % 26.23 % 24.63 % 23.91 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.25 % 78.81 % 82.61 % 78.46 % 86.51 % 88.33 %
Cash Flow Coverage Ratios TTM -2805.91 % 35.55 % 23.81 % 37.92 % 91.41 % 45.35 %
Price To Free Cash Flows Ratio TTM -0.18 30.26 24.41 29.67 51.41 24.2
Price To Operating Cash Flows Ratio TTM -0.65 23.87 20.2 23.3 44.97 21.44
Price Cash Flow Ratio TTM -0.65 23.87 20.2 23.3 44.97 21.44
Income Statement (TTM)
APDN DHR-PB TMO DHR IDXX A
Revenue $0B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0B $14.21B $17.7B $14.21B $2.38B $3.54B
Gross Profit Ratio 29.63% 59.5% 41.28% 59.5% 61.04% 54.3%
EBITDA $-0.01B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -1.82 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
APDN DHR-PB TMO DHR IDXX A
Long Term Debt $0B $15.5B $29.06B $15.5B $0.55B $3.49B
Total Liabilities $0B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0.01B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $0B $16.01B $31.28B $16.01B $0.99B $3.57B
Total Assets $0.01B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
APDN DHR-PB TMO DHR IDXX A
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $-0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.01B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 113.5
ACRS Aclaris Therapeutics, Inc. 1.53
ADVB Advanced Biomed Inc. Common Stock 0.4274
AKU Akumin Inc. 0.2887
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.3632
BIAF bioAffinity Technologies, Inc. 0.2936
BIAFW bioAffinity Technologies, Inc. 0.1351
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 2.95
BNR Burning Rock Biotech Limited 5.67
CDNA CareDx, Inc 12.22
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.6772
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 166.91
CSTL Castle Biosciences, Inc. 14.65
DGX Quest Diagnostics Incorporated 170.85
DHR Danaher Corporation 197.09
ETFs With Exposure to APDN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 305.74
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 135.8
VXF Vanguard Extended Market Index Fund 0 193.64
VTSAX Vanguard Total Stock Market Index Fund 0 148.89
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.9
VITSX Vanguard Total Stock Market Index Fund 0 148.91
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 146.91
VEMPX Vanguard Extended Market Index InstlPlus 0 362.53
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 279.34
Unlock